These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6393074

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN, Quintiliani R, Nightingale CH.
    Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
    [Abstract] [Full Text] [Related]

  • 3. Cefonicid: an overview of clinical studies in the United States.
    Jacob LS, Layne P.
    Rev Infect Dis; 1984; 6 Suppl 4():S791-802. PubMed ID: 6395272
    [Abstract] [Full Text] [Related]

  • 4. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E, Brogden RN.
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [Abstract] [Full Text] [Related]

  • 5. Treatment of bacterial osteomyelitis and Staphylococcus aureus endocarditis and single-dose therapy for uncomplicated Neisseria gonorrhoeae infections: an overview.
    Mader JT, Reinarz JA.
    Rev Infect Dis; 1984 Sep; 6 Suppl 4():S857-64. PubMed ID: 6395277
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
    Geckler RW, McCormack GD, Goodman JS.
    Rev Infect Dis; 1984 Sep; 6 Suppl 4():S847-52. PubMed ID: 6395275
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M, Deamer RL, Prichard JG.
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ceforanide: antibacterial activity, pharmacology, and clinical efficacy.
    Barriere SL, Mills J.
    Pharmacotherapy; 1982 Jan; 2(6):322-7. PubMed ID: 6762529
    [Abstract] [Full Text] [Related]

  • 13. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
    Chanal M, Cluzel M, Sirot D, Joly B, Sirot J, Cluzel R.
    Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
    [Abstract] [Full Text] [Related]

  • 14. In vitro experience with cefonicid.
    Actor P.
    Rev Infect Dis; 1984 May; 6 Suppl 4():S783-90. PubMed ID: 6522920
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of long-acting cephalosporins in ambulatory therapy.
    Prichard JG.
    Clin Ther; 1988 May; 10(6):688-93. PubMed ID: 3219684
    [Abstract] [Full Text] [Related]

  • 18. [Update on antibiotic therapy. 30) Cefonicid].
    di Nola F.
    Minerva Med; 1985 Apr 14; 76(16):819-25. PubMed ID: 4000526
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.
    Chambers HF, Mills J, Drake TA, Sande MA.
    Rev Infect Dis; 1984 Apr 14; 6 Suppl 4():S870-4. PubMed ID: 6522927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.